Journal of the American College of Cardiology logo Elsevier logo

Publisher: Elsevier

Related content
Volume 38, Number 6, 15 November 2001

< previous issue | all issues | next issue >

Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital
pp. 1589-1595(7)
Authors: Brooks W.H.; McClure R.R.; Jones M.R.; Coleman T.C.; Breathitt L.

Another nail in the coffin of carotid endarterectomy*
pp. 1596-1597(2)
Author: White C.J.

Stenting in small coronary arteries (SISCA) trial - A randomized comparison between balloon angioplasty and the heparin-coated beStent
pp. 1598-1603(6)
Authors: Moer R.; Myreng Y.; Molstad P.; Albertsson P.; Gunnes P.; Lindvall B.; Wiseth R.; Ytre-Arne K.; Kjekshus J.; Golf S.

Stenting for small coronary vessels: a contestable winner*
pp. 1604-1607(4)
Authors: Kastrati A.; Schuhlen H.; Schomig A.

A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial
pp. 1608-1613(6)
Authors: Batchelor W.B.; Mahaffey K.W.; Berger P.B.; Deutsch E.; Meier S.; Hasselblad V.; Fry E.T.; Teirstein P.S.; Ross A.M.; Binanay C.A.; Zidar J.P.; the ATLAST Trial Investigators

Quality of life after balloon angioplasty or stenting for acute myocardial infarction - One-year results from the Stent-PAMI trial
pp. 1614-1621(8)
Authors: Rinfret S.; Grines C.L.; Cosgrove R.S.; Ho K.K.L.; Cox D.A.; Brodie B.R.; Morice M.-C.; Stone G.W.; Cohen D.J.; the Stent-PAMI Investigators

Optimizing stent expansion with new stent delivery systems
pp. 1622-1627(6)
Authors: Takano Y.; Yeatman L.A.; Higgins J.R.; Currier J.W.; Ascencio E.; Kopelson K.A.; Tobis J.M.

Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes
pp. 1628-1632(5)
Authors: Ai M.; Tanaka A.; Ogita K.; Sekinc M.; Numano F.; Numano F.; Reaven G.M.

Cardiovascular effects of carbon monoxide and cigarette smoking
pp. 1633-1638(6)
Authors: Zevin S.; Saunders S.; Gourlay S.G.; Jacob P.; Benowitz N.L.

Interaction between smoking and the glycoprotein IIIa P1A2 polymorphism in Non-ST-elevation acute coronary syndromes
pp. 1639-1643(5)
Authors: Barakat K.; Kennon S.; Hitman G.A.; Aganna E.; Price C.P.; Mills P.G.; Ranjadayalan K.; North B.; Clarke H.; Timmis A.D.

The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction1
pp. 1644-1650(7)
Authors: Zeymer U.; Suryapranata H.; Monassier J.P.; Opolski G.; Davies J.; Rasmanis G.; Linssen G.; Tebbe U.; Schroder R.; Tiemann R.; Machnig T.; Neuhaus K.-L.; for the ESCAMI Investigators

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease
pp. 1662-1667(6)
Authors: Khan B.V.; Navalkar S.; Khan Q.A.; Rahman S.T.; Parthasarathy S.

Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation
pp. 1668-1674(7)
Authors: Levenson J.; Pessana F.; Gariepy J.; Armentano R.; Simon A.

Echo-Doppler mitral flow monitoring: an operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure
pp. 1675-1684(10)
Authors: Capomolla S.; Pinna G.; Febo O.; Caporotondi A.; Guazzotti G.; La Rovere M.T.; Gnemmi M.; Mortara A.; Maestri R.; Cobelli F.

Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure
pp. 1685-1692(8)
Authors: Lebrun F.; Lancellotti P.; Pierard L.A.

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
pp. 1701-1706(6)
Authors: Nagueh S.F.; Ommen S.R.; Lakkis N.M.; Killip D.; Zoghbi W.A.; Schaff H.V.; Danielson G.K.; Quinones M.A.; Tajik A.J.; Spencer W.H.

To ablate or operate? that is the question!*
pp. 1707-1710(4)
Authors: Wigle E.D.; Schwartz L.; Woo A.; Rakowski H.

Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive
pp. 1711-1717(7)
Authors: Greenwood J.P.; Scott E.M.; Stoker J.B.; Mary D.A.S.G.

Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up
pp. 1718-1724(7)
Authors: Wyse D.G.; Friedman P.L.; Brodsky M.A.; Beckman K.J.; Carlson M.D.; Curtis A.B.; Hallstrom A.P.; Raitt M.H.; Wilkoff B.L.; Greene H.L.; for the AVID Investigators

Treatable causes of sudden death: not really ''treatable'' or not really the cause?*
pp. 1725-1727(3)
Authors: Viskin S.; Halkin A.; Olgin J.E.

Coarctation of the aorta: outcome of pregnancy
pp. 1728-1733(6)
Authors: Beauchesne L.M.; Connolly H.M.; Ammash N.M.; Warnes C.A.

Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy
pp. 1734-1740(7)
Authors: Shite J.; Qin F.; Mao W.; Kawai H.; Stevens S.Y.; Liang C.-s.

No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits
pp. 1741-1747(7)
Authors: Przyklenk K.; Li G.; Whittaker P.

Progressive action potential duration shortening and the conversion from atrial flutter to atrial fibrillation in the isolated canine right atrium
pp. 1757-1765(9)
Authors: Wu T.-J.; Kim Y.-H.; Yashima M.; Athill C.A.; Ting C.-T.; Karagueuzian H.S.; Chen P.-S.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page